PLSH (Panacea Life Sciences Holdings) EPS (Basic): $0.05 (TTM As of Sep. 2025)


What is Panacea Life Sciences Holdings EPS (Basic)?

Panacea Life Sciences Holdings PLSH +3.64% EPS (Basic) is $0.05 as of Sep. 2025. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's basic earnings per share (Basic EPS) for the three months ended in Sep. 2025 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was $0.05.

Panacea Life Sciences Holdings's EPS (Diluted) for the three months ended in Sep. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $0.03.

Panacea Life Sciences Holdings's EPS without NRI for the three months ended in Sep. 2025 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was -0.09.

During the past 3 years, the average EPS without NRI Growth Rate was -11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Panacea Life Sciences Holdings's highest 3-Year average EPS without NRI Growth Rate was -11.60% per year. The lowest was -11.60% per year. And the median was -11.60% per year.

Panacea Life Sciences Holdings  (OTCPK:PLSH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Panacea Life Sciences Holdings EPS (Basic) Related Terms

Panacea Life Sciences Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings EPS (Basic) Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Basic)
-0.31 -0.28 -0.62 -0.48

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.06 0.00 0.05 0.00

Panacea Life Sciences Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Panacea Life Sciences Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-8.015-0)/16.627
=-0.48

Panacea Life Sciences Holdings's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.184-0)/42.166
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.05 mean?
Panacea Life Sciences Holdings (PLSH) has a EPS (Basic) of $0.05 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' EPS (Basic) too high?
Panacea Life Sciences Holdings' current EPS (Basic) is $0.05.
How does Panacea Life Sciences Holdings' EPS (Basic) compare to NPHC and OWPC?
Panacea Life Sciences Holdings' EPS (Basic) of $0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current EPS (Basic) is $0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current EPS (Basic) of $0.05. The current EPS (Basic) is $0.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current EPS (Basic) is $0.05 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.